Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

225 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Muscle weakness and mitochondrial stress occur before metastasis in a novel mouse model of ovarian cancer cachexia.
Delfinis LJ, Ogilvie LM, Khajehzadehshoushtar S, Gandhi S, Garibotti MC, Thuhan AK, Matuszewska K, Pereira M, Jones RG 3rd, Cheng AJ, Hawke TJ, Greene NP, Murach KA, Simpson JA, Petrik J, Perry CGR. Delfinis LJ, et al. Among authors: petrik j. bioRxiv [Preprint]. 2024 Apr 8:2024.04.08.588639. doi: 10.1101/2024.04.08.588639. bioRxiv. 2024. PMID: 38645227 Free PMC article. Preprint.
Recombinant Newcastle disease viruses expressing immunological checkpoint inhibitors induce a pro-inflammatory state and enhance tumor-specific immune responses in two murine models of cancer.
Santry LA, van Vloten JP, AuYeung AWK, Mould RC, Yates JGE, McAusland TM, Petrik JJ, Major PP, Bridle BW, Wootton SK. Santry LA, et al. Among authors: petrik jj. Front Microbiol. 2024 Jan 24;15:1325558. doi: 10.3389/fmicb.2024.1325558. eCollection 2024. Front Microbiol. 2024. PMID: 38328418 Free PMC article.
Kinetic analysis of oncolytic OrfV-induced innate and adaptive immune responses in a murine model of late-stage ovarian cancer.
Minott JA, van Vloten JP, Yates JGE, Santry LA, Matuszewska K, Pereira M, Goens MM, Viloria-Petit AM, Wood GA, Karimi K, Petrik JJ, Bridle BW, Wootton SK. Minott JA, et al. Among authors: petrik jj. Mol Ther Oncolytics. 2023 Nov 10;31:100748. doi: 10.1016/j.omto.2023.100748. eCollection 2023 Dec 19. Mol Ther Oncolytics. 2023. PMID: 38075247 Free PMC article.
Comparative analysis of syngeneic mouse models of high-grade serous ovarian cancer.
Cook DP, Galpin KJC, Rodriguez GM, Shakfa N, Wilson-Sanchez J, Echaibi M, Pereira M, Matuszewska K, Haagsma J, Murshed H, Cudmore AO, MacDonald E, Tone A, Shepherd TG, Petrik JJ, Koti M, Vanderhyden BC. Cook DP, et al. Among authors: petrik jj. Commun Biol. 2023 Nov 13;6(1):1152. doi: 10.1038/s42003-023-05529-z. Commun Biol. 2023. PMID: 37957414 Free PMC article.
Liposomal delivery of gene therapy for ovarian cancer: a systematic review.
Son JS, Chow R, Kim H, Lieu T, Xiao M, Kim S, Matuszewska K, Pereira M, Nguyen DL, Petrik J. Son JS, et al. Among authors: petrik j. Reprod Biol Endocrinol. 2023 Aug 23;21(1):75. doi: 10.1186/s12958-023-01125-2. Reprod Biol Endocrinol. 2023. PMID: 37612696 Free PMC article. Review.
Thrombospondins in the tumor microenvironment.
Petrik J, Lauks S, Garlisi B, Lawler J. Petrik J, et al. Semin Cell Dev Biol. 2024 Mar 1;155(Pt B):3-11. doi: 10.1016/j.semcdb.2023.05.010. Epub 2023 Jun 5. Semin Cell Dev Biol. 2024. PMID: 37286406 Review.
Serum and lymph pharmacokinetics of nilotinib delivered by yeast glucan particles per os.
Šalamúnová P, Krejčí T, Ryšánek P, Saloň I, Kroupová J, Hubatová-Vacková A, Petřík J, Grus T, Lukáč P, Kozlík P, Křížek T, Dammer O, Beránek J, Šíma M, Slanař O, Štěpánek F. Šalamúnová P, et al. Among authors: petrik j. Int J Pharm. 2023 Mar 5;634:122627. doi: 10.1016/j.ijpharm.2023.122627. Epub 2023 Jan 21. Int J Pharm. 2023. PMID: 36693484
225 results